Nexera updates prospectus for 34K share offering
Nexera Technologies Ltd (NEXR) filed a prospectus supplement to update its existing Form F-1 prospectus covering the offering of up to 34,077 Ordinary Shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nexera Technologies Ltd (NEXR) filed a prospectus supplement to update its existing Form F-1 prospectus covering the offering of up to 34,077 Ordinary Shares. The supplement incorporates Nexera’s latest Form 6-K, which includes unaudited condensed consolidated financial statements and management’s discussion and analysis for the six months ended June 30, 2026.
The company’s Ordinary Shares and public warrants trade on the Nasdaq Capital Market under the symbols NEXR and NEXRW. On August 31, 2026, the last reported sale prices were $1.86 per Ordinary Share and $0.0128 per Public Warrant. The supplement also notes that the related promissory notes are not listed on any exchange.
Filing Explained
Beyond updating the F-1 prospectus, the
Key Figures
Key Terms
Prospectus supplement regulatory
Report of Foreign Private Issuer regulatory
Form 6-K regulatory
Inline XBRL technical
Form F-3 regulatory
Form S-8 regulatory
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Nexera Technologies Ltd (NEXR) register in this prospectus supplement?
What new information about NEXR is incorporated by reference in this supplement?
Are Nexera Technologies Ltd’s promissory notes listed on an exchange?
Which other registration statements does NEXR’s Form 6-K become part of?
Where are NEXR’s risk factors for this offering discussed?
AI-generated analysis. How Rhea-AI works. Not financial advice.